Drawing for BIOCSL

USPTO serial 79128394

BIOCSL

Reviewed by CopyMark Law Group

Reg. 4493063Status 404
Filing date
Status date
Registration date
Mar 11, 2014
Examiner
WIENER, MICHAEL
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIOCSL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nancy Sabarra

Nancy Sabarra Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd St., 17th Fl.New York, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment and/or prevention of blood or bleeding disorders; vaccines; blood products in this class, namely, blood plasma, reagent blood cells; products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use; serums, namely, anti-venoms; medicated serums for the treatment of blood or bleeding disorders; test kits in the class, namely, invitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substances, namely, RhD reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies or IgG subtypes; pharmaceutical preparations, namely, monoclonal and polyclonal antibodies ; pharmaceutical preparations, namely, reagents for medical/clinical use for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypesSECTION 71 - CANCELLED
010Surgical and medical apparatus and instruments for use in intravenous administration of pharmaceutical and blood products for the treatment of blood or bleeding disorders and vaccines; analysis apparatus and instruments in this class, namely, apparatus for blood analysisSECTION 71 - CANCELLED
044Medical services; providing medical information concerning blood products; providing medical information concerning vaccines, anti-venoms and immunohaematology products, namely, diagnostic reagents; patient support services, namely, providing an Internet-based database of patient medical information where patients can enquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and communitySECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 9, 2023DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jul 9, 2023DETHDEATH OF INTERNATIONAL REGISTRATION
Mar 6, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB
Feb 11, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 11, 2022INPCINVALIDATION PROCESSED
Oct 26, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 26, 2021C71TCANCELLED SECTION 71
Nov 25, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 25, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 11, 2019REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 17, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 27, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED
May 18, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 10, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED
Dec 16, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED
Jul 1, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 1, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 22, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jun 23, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB
Jun 23, 2014FIMPFINAL DISPOSITION PROCESSED
Jun 11, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 11, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 24, 2013GPNXNOTIFICATION PROCESSED BY IB
Dec 24, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 24, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 4, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 4, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 4, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 18, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 13, 2013ALIEASSIGNED TO LIE
Oct 25, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 24, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Oct 24, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 24, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 18, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 18, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 26, 2013RFNTREFUSAL PROCESSED BY IB
May 3, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 3, 2013RFRRREFUSAL PROCESSED BY MPU
May 3, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 2, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 30, 2013MAFRAPPLICATION FILING RECEIPT MAILED
Apr 26, 2013DOCKASSIGNED TO EXAMINER
Apr 26, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 25, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance